Adverse prognostic impact of KIT mutations in childhood CBF-AML: The results of the Japanese Pediatric Leukemia/Lymphoma Study Group AML-05 trial

M. Tokumasu; C. Murata; A. Shimada; K. Ohki; Y. Hayashi; A. M. Saito; J. Fujimoto; K. Horibe; M. Nagao; H. Itoh; Y. Kamikubo; H. Nakayama; A. Kinoshita; D. Tomizawa; T. Taga; A. Tawa; S. Tanaka; T. Heike; S. Adachi

doi:10.1038/leu.2015.121

Adverse prognostic impact of KIT mutations in childhood CBF-AML: The results of the Japanese Pediatric Leukemia/Lymphoma Study Group AML-05 trial

M. Tokumasu, C. Murata, A. Shimada, K. Ohki, Y. Hayashi, A. M. Saito, J. Fujimoto, K. Horibe, M. Nagao, H. Itoh, Y. Kamikubo, H. Nakayama, A. Kinoshita, D. Tomizawa, T. Taga, A. Tawa, S. Tanaka, T. Heike, S. Adachi

University Hospital

Research output: Contribution to journal › Letter › peer-review

25 Citations (Scopus)

Original language	English
Pages (from-to)	2438-2441
Number of pages	4
Journal	Leukemia
Volume	29
Issue number	12
DOIs	https://doi.org/10.1038/leu.2015.121
Publication status	Published - Dec 1 2015

ASJC Scopus subject areas

Hematology
Oncology
Cancer Research

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1038/leu.2015.121

Cite this

Tokumasu, M., Murata, C., Shimada, A., Ohki, K., Hayashi, Y., Saito, A. M., Fujimoto, J., Horibe, K., Nagao, M., Itoh, H., Kamikubo, Y., Nakayama, H., Kinoshita, A., Tomizawa, D., Taga, T., Tawa, A., Tanaka, S., Heike, T., & Adachi, S. (2015). Adverse prognostic impact of KIT mutations in childhood CBF-AML: The results of the Japanese Pediatric Leukemia/Lymphoma Study Group AML-05 trial. Leukemia, 29(12), 2438-2441. https://doi.org/10.1038/leu.2015.121

Tokumasu, M, Murata, C, Shimada, A, Ohki, K, Hayashi, Y, Saito, AM, Fujimoto, J, Horibe, K, Nagao, M, Itoh, H, Kamikubo, Y, Nakayama, H, Kinoshita, A, Tomizawa, D, Taga, T, Tawa, A, Tanaka, S, Heike, T & Adachi, S 2015, 'Adverse prognostic impact of KIT mutations in childhood CBF-AML: The results of the Japanese Pediatric Leukemia/Lymphoma Study Group AML-05 trial', Leukemia, vol. 29, no. 12, pp. 2438-2441. https://doi.org/10.1038/leu.2015.121

@article{eaef439585bc46d688b0bad73bfc4925,

title = "Adverse prognostic impact of KIT mutations in childhood CBF-AML: The results of the Japanese Pediatric Leukemia/Lymphoma Study Group AML-05 trial",

author = "M. Tokumasu and C. Murata and A. Shimada and K. Ohki and Y. Hayashi and Saito, {A. M.} and J. Fujimoto and K. Horibe and M. Nagao and H. Itoh and Y. Kamikubo and H. Nakayama and A. Kinoshita and D. Tomizawa and T. Taga and A. Tawa and S. Tanaka and T. Heike and S. Adachi",

note = "Funding Information: This work was supported by a grant for a Grant-in-Aid for Cancer Research from the Ministry of Health, Labor, and Welfare of Japan (H26-061).",

year = "2015",

month = dec,

day = "1",

doi = "10.1038/leu.2015.121",

language = "English",

volume = "29",

pages = "2438--2441",

journal = "Leukemia",

issn = "0887-6924",

publisher = "Nature Publishing Group",

number = "12",

}

TY - JOUR

T1 - Adverse prognostic impact of KIT mutations in childhood CBF-AML

T2 - The results of the Japanese Pediatric Leukemia/Lymphoma Study Group AML-05 trial

AU - Tokumasu, M.

AU - Murata, C.

AU - Shimada, A.

AU - Ohki, K.

AU - Hayashi, Y.

AU - Saito, A. M.

AU - Fujimoto, J.

AU - Horibe, K.

AU - Nagao, M.

AU - Itoh, H.

AU - Kamikubo, Y.

AU - Nakayama, H.

AU - Kinoshita, A.

AU - Tomizawa, D.

AU - Taga, T.

AU - Tawa, A.

AU - Tanaka, S.

AU - Heike, T.

AU - Adachi, S.

N1 - Funding Information: This work was supported by a grant for a Grant-in-Aid for Cancer Research from the Ministry of Health, Labor, and Welfare of Japan (H26-061).

PY - 2015/12/1

Y1 - 2015/12/1

UR - http://www.scopus.com/inward/record.url?scp=84951567209&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84951567209&partnerID=8YFLogxK

U2 - 10.1038/leu.2015.121

DO - 10.1038/leu.2015.121

M3 - Letter

C2 - 25975190

AN - SCOPUS:84951567209

SN - 0887-6924

VL - 29

SP - 2438

EP - 2441

JO - Leukemia

JF - Leukemia

IS - 12

ER -

Adverse prognostic impact of KIT mutations in childhood CBF-AML: The results of the Japanese Pediatric Leukemia/Lymphoma Study Group AML-05 trial

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Cite this